Overall Status

Completed (626)

Unknown status (198)

Recruiting (178)

Not yet recruiting (135)

Terminated (39)

Active, not recruiting (27)

Withdrawn (26)

Enrolling by invitation (20)

Suspended (4)

Phase

n/a (480)

phase 4 (154)

phase 3 (105)

phase 2 (92)

phase 1/phase 2 (33)

phase 1 (32)

phase 2/phase 3 (28)

early phase 1 (16)

Study Documents

Study Protocol (4)

Individual Participant Data Set (3)

Annotated Case Report Form (1)

Clinical Study Report (1)

Dataset Specification (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study design, -summary, -files; participant demographics, et al. (1)

Study summary, -design, -assessments, -adverse events, -intervention(s), -study files et al. (1)

Funder Type

Other (1,091)

Industry (128)

U.S. Fed (18)

NIH (16)

Study Type

Interventional (941)

Observational (280)

Observational [Patient Registry] (32)

Antimicrobial stewardship

Showing 1251 - 1253 of 1,253

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Mycobacterium Avium-Intracellulare Infection, HIV Trial in Hampton (Rifapentine, Ethambutol HCl, Clarithromycin)

Completed

Mycobacterium Avium-Intracellulare Infection
HIV Infections

Rifapentine
+3 more

Hampton, Virginia

Hampton Roads Med Specialists

Jun 23, 2005

HIV Trial in New York (Nitazoxanide)

Completed

HIV Infections

Nitazoxanide

New York, New York

New York Hosp / Cornell Med Ctr

Jun 23, 2005

Atopic Dermatitis, Eczema Trial in United States (Nanocrystalline silver cream (NPI))

Completed

Atopic Dermatitis
Eczema

Nanocrystalline silver cream (NPI)

Birmingham, Alabama
+18 more

Jun 23, 2005